A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US

AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)

NCT02141672 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

NCT02550652 ·Status: COMPLETED ·Phase: PHASE2

Aurinia Early Urinary Protein Reduction Predicts Response

NCT02949973 ·Status: COMPLETED ·Phase: PHASE2

Pentoxifylline in Lupus Nephritis

NCT03859570 ·Status: WITHDRAWN ·Phase: PHASE4

Drug Therapy in Lupus Nephropathy

NCT00001212 ·Status: COMPLETED ·Phase: PHASE2

A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

NCT06406205 ·Status: RECRUITING ·Phase: PHASE3

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

NCT02770170 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

NCT04221477 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Lupus Landmark Study: A Prospective Registry and Biorepository

NCT05934149 ·Status: RECRUITING

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

NCT07225387 ·Status: RECRUITING ·Phase: PHASE4

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

NCT03385564 ·Status: COMPLETED ·Phase: PHASE2

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

NCT07175285 ·Status: RECRUITING

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

NCT04835441 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

NCT00035308 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

NCT05268289 ·Status: RECRUITING ·Phase: PHASE2

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT05938725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis

NCT04924296 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

NCT00709722 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Identifying New Therapeutic Targets for Lupus Treatment

NCT03921398 ·Status: COMPLETED

CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus

NCT05930314 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis

NCT04883619 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619 ·Status: RECRUITING ·Phase: PHASE2

Dapagliflozin in Active Lupus Nephritis

NCT07323524 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis

NCT01273389 ·Status: COMPLETED ·Phase: PHASE2

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

NCT05207358 ·Status: RECRUITING ·Phase: PHASE4